Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

RANDOMIZED TRIAL OF IMPACT OF MULTIPLE INTERVENTIONS ON HIV RESERVOIR: SPARC-7 TRIAL

By Enthusiast Inc MDMarch 6, 2019

…(ART+DTG+MVC+Au), G5) partially intensified ART (DTG)+DCv, G6) partially intensified ART (DTG)+NA+Auranofin+DCv. Au was used for the first 24 weeks. DC was pulsed with autologous Gag256-367 peptides (nanomers, 3-6 peptides each…

IL-15 Induces Id2 to Drive Effector Differentiation of CD8 TM and EM Cells while Maintaining CM Pools

By Enthusiast Inc MDSeptember 29, 2014

…peptide. At day five we measured activation (Ki67, GrzB) and differentiation of tetramer positive cells (Id2 levels and CCR7,CD27,CD45RA). Cytolytic activity was measured by a cell-based assay that measures the…

CSF HIV-TAT AS A BIOMARKER OF NEUROCOGNITION AND AGING IN HIV-INFECTED PATIENTS

By Enthusiast Inc MDMarch 5, 2019

…between Tat and amyloid beta (Aβ) peptide. Tat was measured by ELISA in CSF of patients with HIV infection on antiretroviral therapy. Evaluations included neurocognitive tests, CSF cytokines, Aβ peptide,…

429 – A Novel Immunotherapeutic Platform for Amplifying HIV, CMV, or SARS-CoV-2-Specific T-Cell Responses

By Jimmy He PharmD, DScMarch 20, 2025

…conserved virus-derived peptide antigens.  Methods We constructed plasmids encoding single chain HLA-A*0201 MHC molecules tethered to viral-derived peptides, either alone (modless) or in combination with an agonist αCD28 scFv, to…

Immunogenicity of Cleaved Soluble BG505 SOSIP.664 Native-Like Trimers in Rabbits

By Enthusiast Inc MDSeptember 29, 2014

…now is to combine knowledge of the BG505 SOSIP.664 trimer structure with a better understanding of the immunology of bNAb development during infection, to guide improvements to Env trimer-based immunogens….

ANTIRETROVIRAL REGIMEN DURABILITY IS NOT DRIVEN BY VIRAL FAILURE IN AN AFRICAN COHORT

By Enthusiast Inc MDMarch 7, 2019

…was efavirenz/lamivudine/tenofovir disoproxl fumarate. The median duration of this regimen was 2.25 (IQR 0.94-3.88) years. The initial regimen was switched or stopped for 1207 (45%) participants for reasons including change…

GAPS ALONG THE PrEP CONTINUUM AMONG STD CLINIC ATTENDING MSM WITH HIGH RISK BEHAVIORS

By Enthusiast Inc MDMarch 6, 2018

…for survey year, race, insurance, income, number of casual partners, HIV tests in the last year, and having heard of and used post-exposure prophylaxis (PEP). Among 460 participants, 53 (12%)…

EVALUATION OF THE CEPHEID HIV-1 QUAL POINT-OF-CARE TEST FOR HIV DIAGNOSIS AT BIRTH

By Enthusiast Inc MDFebruary 15, 2017

…and specificity for the Cepheid POC assay in the first week of life despite low median infant HIV RNA and extensive PEP. The Cepheid POC testing platform may be a…

40 – Long-Acting Preexposure Prophylaxis: Why Can’t We Get to Scale?

By Jimmy He PharmD, DScMarch 18, 2025

…Fund, PEPFAR, and the Bill and Melinda Gates Foundation (BMGF) announced efforts to ensure two million people have equitable access to affordable Lenacapavir for three years. Recent termination of several PEPFAR…

HIV PREVENTION AND DRUG-USER HEALTH CARE ON SITE AT A SYRINGE -EXCHANGE PROGRAM

By Jimmy He PharmD, DScApril 27, 2020

…an academic medical center and an SEP to deliver low barrier healthcare to people who use drugs (PWUD) onsite at an SEP.   A Montefiore Medical Center clinic was opened…

←1
2345678910111213141516171819202122232425262728
…2930313233…
34353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top